An announcement by the Princess Máxima Center for pediatric oncology, a center that brings together the complex care and research for children with cancer in the Netherlands, describes a new research effort supported by FCF. In this new study, Benedetta Artegiani will apply her experience researching organoids to determine the role BAP1 plays in fibrolamellar carcinoma. The hope is that better understanding the role of different genetic drivers of FLC could help identify new targets for treatments for the disease.

Click here to read the Princess Máxima Center’s announcement of their research effort.